Not long after the first Omicron infections in Australia, Therapeutics company Moderna said it was prepared to develop a specific booster shot for Omicron if necessary to help curb the spread of the new variant.
Moderna said it had already been testing variant specific boosters and was already working on an Omicron version.
The three most crucial questions about Omicron, according to Moderna, were:
– How transmissible is the variant?
– How severe is the new variant?
– Are current COVID-19 vaccines going to be effective against Omicron?